Page last updated: 2024-11-02

pamidronate and Psoriasis

pamidronate has been researched along with Psoriasis in 2 studies

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Galadari, H1
Bishop, AG1
Venna, SS1
Sultan, E1
Do, D1
Zeltser, R1
Collange, C1
Brantus, JF1
Sidot, C1
Meunier, PJ1

Other Studies

2 other studies available for pamidronate and Psoriasis

ArticleYear
Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.
    Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:1

    Topics: Acneiform Eruptions; Diphosphonates; Drug Therapy, Combination; Humans; Hyperostosis; Isotretinoin;

2009
Sapho syndrome with femoral hyperostosis. Two case-reports.
    Revue du rhumatisme (English ed.), 1996, Volume: 63, Issue:5

    Topics: Adult; Antirheumatic Agents; Diphosphonates; Female; Femur; Humans; Hyperostosis; Magnetic Resonance

1996